| P2093 | author name string | Beatrix Schwerer | |
| P2860 | cites work | Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies | Q28140367 |
| | Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal | Q28186978 |
| | Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome | Q28256385 |
| | Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection | Q28284306 |
| | Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome | Q28297319 |
| | Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits | Q28360460 |
| | Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome | Q28379144 |
| | CD1-restricted T cell recognition of microbial lipoglycan antigens | Q28610594 |
| | Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome | Q31810977 |
| | Autoantibodies associated with peripheral neuropathy | Q33682810 |
| | The immunopathogenesis of Miller Fisher syndrome | Q33850688 |
| | Pathogenesis of Guillain-Barré syndrome | Q33850709 |
| | Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. | Q33853670 |
| | Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection | Q33867225 |
| | Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group | Q34396132 |
| | Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection | Q34502701 |
| | Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections | Q34746556 |
| | Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects | Q36399818 |
| | Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome | Q36760346 |
| | Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides | Q36900370 |
| | A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. | Q37352303 |
| | A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure | Q38314715 |
| | Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. | Q39825594 |
| | Gangliosides and bacterial toxins in Guillain-Barré syndrome | Q40840074 |
| | Human autoimmune neuropathies | Q40864286 |
| | Self glycolipids as T-cell autoantigens | Q40950196 |
| | Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides | Q42277587 |
| | Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility | Q42540247 |
| | Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies | Q42541304 |
| | Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome | Q42546776 |
| | Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha | Q42549991 |
| | Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome | Q42551135 |
| | Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis | Q42551712 |
| | Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides | Q42669740 |
| | N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome | Q47965418 |
| | Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro | Q48194734 |
| | Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies | Q48194753 |
| | The distribution of ganglioside-like moieties in peripheral nerves | Q48254142 |
| | Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome | Q48467853 |
| | The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons | Q48552904 |
| | High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. | Q52539606 |
| | Campylobacter jejuni infection and Guillain-Barré syndrome. | Q55063212 |
| | Acute motor axonal neuropathy: An antibody-mediated attack on axolemma | Q57197741 |
| | Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy | Q57197743 |
| | Pathology of the motor-sensory axonal Guillain-Barré syndrome | Q57197745 |
| | Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies | Q70514545 |
| | Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide | Q70744150 |
| | Mycoplasma antibody in Guillain-Barré syndrome and other neurological disorders | Q71176548 |
| | Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome | Q71444464 |
| | HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection | Q71586078 |
| | Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome | Q71705948 |
| | Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients | Q71886702 |
| | Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer | Q72153374 |
| | Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers | Q72157843 |
| | IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses | Q72191304 |
| | Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome | Q72273079 |
| | Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides | Q72607999 |
| | Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases | Q72889696 |
| | Haemophilus influenzae infection and Guillain-Barré syndrome | Q72998265 |
| | Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a | Q73302190 |
| | Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome | Q73336434 |
| | Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome | Q73515431 |
| | Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside | Q73546528 |
| | Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy | Q74196573 |
| | Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes | Q74377577 |
| | Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy | Q74595019 |
| | HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome | Q77114331 |
| | Guillain-Barré syndrome | Q77326744 |
| | Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group | Q77568588 |
| | Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies | Q77663476 |
| | Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis | Q77779798 |
| | Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates | Q78170867 |
| P433 | issue | 3 | |
| P921 | main subject | antibody | Q79460 |
| | Guillain–Barré syndrome | Q205214 |
| P304 | page(s) | 373-384 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Microbes and Infection | Q15760242 |
| P1476 | title | Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome | |
| P478 | volume | 4 | |